Abbott Partners with NIH on BRAIN Initiative to Use Neuromodulation Technologies

Abbott Partners with NIH on BRAIN Initiative to Use Neuromodulation Technologies
Abbott is partnering with the National Institutes of Health (NIH) to explore the use of its neuromodulation technologies for treating chronic pain and progressive movement disorders, including Parkinson’s disease. The partnership’s goal is to drive forward the Brain Research through Advancing Innovative Neurotechnologies initiative, known as BRAIN, which is working to accelerate neuroscience research. With this collaboration agreement, Abbott will ... read more
Source: Parkinson’s News TodayPublished on 2019-05-16By Joana Carvalho